Please login to the form below

Not currently logged in
Email:
Password:

Epanutin

This page shows the latest Epanutin news and features for those working in and with pharma, biotech and healthcare.

Pfizer gets record £84m fine for hiking price of epilepsy drug

Pfizer gets record £84m fine for hiking price of epilepsy drug

Pfizer said it "refutes the findings" and will appeal. The allegations centre on Pfizer's sale of its branded product sold as Epanutin to Flynn at that time, which promptly genericised ... Pfizer maintains that its divestment of Epanutin "fully complies

Latest news

  • Pfizer and Flynn accused of overcharging for epilepsy drug Pfizer and Flynn accused of overcharging for epilepsy drug

    Pfizer and Flynn accused of overcharging for epilepsy drug. UK watchdog investigating the firms over the millions of pounds spent on Epanutin. ... Pfizer's brand name for the drug in the UK was Epanutin and according to the CMA the NHS spent around

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics